News Details

( As on 12/01/2019 12:46)

Aspira Pathlab & Dia - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results.

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2019 ,inter alia, to consider and approve We wish to inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Monday, January 21, 2019 to consider and approve, inter alia, the unaudited financial results of the Company for the third quarter and nine months ended December 31, 2018.
Pursuant to Company's Internal Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from Monday, January 14, 2019 and shall open 48 hours after announcement of the outcome of the said meeting, for all its designated persons.